A Study of DSP-2033 (Alvocidib) in Patients With Acute Myeloid Leukemia
Clinical trial NCT03563560 · COMPLETED
Trial details
- NCT number
- NCT03563560
- Sponsor
- Sumitomo Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-15
- Primary completion
- 2020-03-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.